TCT 2010 roundup
September 22, 2010 by MassDevice staff
Medical device makers are flocking to this year's Transcatheter Cardiovascular Therapeutics conference in Washington, D.C., eager to tout the results of clinical trials and new products to some 12,000 cardiologists and other healthcare professionals.
A major battlefield in the stent wars opens again this week, as thousands of cardiologists and other healthcare providers flock to Washington, D.C., for the annual Transcatheter Cardiovascular Therapeutics conference.
Medical device industry players large and small are busy hawking the results of clinical trials and touting new products — or new versions of older products. TCT 2010, which kicked off yesterday, is slated to run through Sept. 25.
- Show full page
- Login to post comments
-
Permalink
RECENT BLOG POSTS
- Is Valeant About To Make A Bold Bid For Bausch & Lomb?
- When regulators are ignored
- FDA Issues Draft Guidance to Help Companies Distinguish Between a Voluntary Medical Device Recall and a Product Enhancement
- Patient and family engagement in ICUs
- A day in the life: A pediatric neurosurgeon's vision
- Medical Device Tax: Are Conservatives' goals hampering repeal efforts?
- Personal health record use by adolescents
- Can Johnson & Johnson fire on all cylinders again?
- U.S. FDA to require proof of IEC 60601-1 3rd Edition in summer 2013
- A cure for coffee breath?
Navigation
NEWS
Uroplasty touts positive 3-year outcomes for neurostimulation in treatment of overactive bladder
Covidien’s 3-year study results showing positive outcomes for its Urgent PC Neuromodulation system in...
FDA clears 21-inch medical monitors from NEC Display Solutions
NEC Display Solutions wins 510(k) clearance for its 21-inch medical monitor systems.
Johnson and Johnson executive splits for the corner office at Itamar Medical | Personnel Moves
J&J's former head of global cardiology makes the jump to CEO at Itamar Medical
Sunshine Heart seeks $25.5M in equity funding round | Wall Street Beat
Sunshine Heart raises $1.5 million of a hoped-for $25.5 million equity funding round.
J&J sues Shasta Technologies for logo infringement
J&J subsidiary Lifescan asks the courts to ban Shasta from using its logo, saying problems with...
